COPING STRATEGIES IN PATIENTS WITH PROSTATE CANCER

Diagnostics of psycho-emotional disorders of patients with malignant diseases of the prostate is not doubt, because timely correction contributes to the shortening of rehabilitation period and restoration of the quality of life of patients after treatment. Detection and diagnosis of prostate cancer for many patients is stressful and causes changes in the affective sphere, and manifests itself in increased levels of anxiety and depression in men. To cope with stress is possible due to the used coping strategies.
Purpose. Studying the coping mechanisms in prostate cancer patients.
Materials and methods. 56 men treated in FGBU "LRTS" Russian Ministry of Health. The average age was 65.7 ± 6.1 years. The average duration of the disease prostate cancer is 3 ± 2 months. All men were subjected to the standard algorithm for the evaluation of hormonal status, the PSA, taking a history, inspection and physical examination, magnetic resonance imaging and scintigraphy of bones of a skeleton. All the patients underwent laparoscopic radical prostatectomy. Psychological testing with the use of the method of "Coping test" the scale of reactive and personal anxiety for the differentiated evaluation of anxiety. 
Results. The most common for prostate cancer revealed constructive coping strategies are "planning solve", "selfcontrol" and "search of social support". According to the scale Spielberg–Hanin a high level of situational anxiety was revealed.
Conclusion. According to the results of the research, patients with prostate cancer are likely to use constructive coping strategies, that leads to stabilization of psycho-emotional state of men and promotes more effective adaptation in the terms of stress, that is caused by treatment of prostate cancer.

1. Schreiber D., Rineer J., Weiss J. P., Safdieh J., Weiner J., Rotman M., Schwartz D.et al. Clinical and biochemical outcomes of men undergoing radical prostatectomy or radiation therapy for localized prostate cancer. Radiat Oncol J. 2015; 33 (1): 21–28.

2. Stone A. A., Mezzacappa E. S., Donatone B. A., Gonder M. Psychosocial stress and social support are associated with prostate-specific antigen levels in men: results from a community screening program. Health Psychol. 1999; 18 (5): 482–486.

3. Spiegel D., Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry. 2003; 54 (3): 269–282.

4. Kryukova T. L., Kuftyak E. V. Oprosnik sposobov sovladaniya (adaptatsiya metodiki WCQ). Zhurnal prakticheskogo psikhologa. 2007; 3: 93–112. (Russian).

5. Chissov V. I., Starinskii V. V., Petrova G. V. (eds). Zlokachestvennye novoobrazovaniya v Rossii v 20010 godu (zabolevaemost' i smertnost'). Moscow: FGU «MNIOI im. P. A. Gertsena Rosmedtekhnologii», 2012. (Russian).

6. Lazarus R. S. Psychological Stress and the Coping Process. New-York: McGraw-Hill, 1966.

7. Aizer A. A., Paly J. J., Zietman A. L., Nguyen P. L., Beard C. J., Rao S. K., Kaplan I. D., Niemierko A., Hirsch M. S., Wu C. L., Olumi A. F., Michaelson M. D., D'Amico A. V., Efstathiou J. A. Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer. J Clin Oncol. 2012; 30 (25): 3071–3076.

8. Mohler J. L., Armstrong A. J., Bahnson R. R., Boston B., Busby J. E., D'Amico A. V., Eastham J. A., Enke C. A., Farrington T., Higano C. S., Horwitz E. M., Kantoff P. W., Kawachi M. H., Kuettel M., Lee R. J., MacVicar G. R., Malcolm A. W., Miller D., Plimack E. R., Pow-Sang J. M., Roach M 3rd., Rohren E., Rosenfeld S., Srinivas S., Strope S. A., Tward J., Twardowski P., Walsh P. C., Ho M., Shead D. A. Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2012; 10 (9): 1081–1087.

9. Saxe G. A., Major J. M., Nguyen J. Y., Freeman K. M., Downs T. M., Salem C. E. Potential attenuation of disease progression in recurrent prostate cancer with plant-based diet and stress reduction. Integr Cancer Ther. 2006; 5 (3): 206–213.

10. Kang H. W., Lee J. Y., Kwon J. K., Jeh S. U., Jung H. D., Choi Y. D. Current status of radical prostatectomy for high-risk prostate cancer. Korean J Urol. 2014; 55 (10): 629–635.